États-Unis · Plateformes & données · MarketBeat
Insider Buying: Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Acquires $20,250.00 in Stock
Résumé détaillé
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Get Free Report) CEO Seth Lederman acquired 5,000 shares of the stock in a transaction dated Wednesday, November 11th. The stock was acquired at an average price of $4.05 per share, with a total value of $20,250.00. Following the completion of the acquisition, the chief executive officer owned 16,005 shares in the company, valued at approximately $64,820.25.
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)
